Evidence-based Advances in the Knowledge and Management of Adverse Events of Immunotherapy for Cancer - Volume III

7,284
Total downloads
24k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 03 Mar 2023

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma—A network meta-analysis. Focus on cabozantinib combined with nivolumab

Maciej Niewada
Tomasz Macioch
Magdalena Konarska
Aneta Mela
Adam Goszczyński
Bogusława Przekopińska
Karolina Rajkiewicz
Piotr Wysocki
Maciej Krzakowski

doi 10.3389/fphar.2022.1063178

3,903 views
5 citations

ORIGINAL RESEARCH

Published on 26 Jan 2023

Immune checkpoint inhibitor-induced aplastic anaemia: Case series and large-scale pharmacovigilance analysis

Qian Guo
Jin Ning Zhao
Ting Liu
Jian Gao
Hui Guo
Jing Min Cheng

doi 10.3389/fphar.2023.1057134

4,145 views
2 citations

REVIEW

Published on 28 Nov 2022

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives

Bilal Zulfiqar
Asim Farooq
Shahzina Kanwal
Kashif Asghar

doi 10.3389/fphar.2022.1035171

10,585 views
28 citations

ORIGINAL RESEARCH

Published on 05 Jul 2022

Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data

Yanna Lei
Xiufeng Zheng
Qian Huang
Xiaoying Li
Meng Qiu
Ming Liu

doi 10.3389/fphar.2022.914928

2,813 views
5 citations

SYSTEMATIC REVIEW

Published on 25 May 2022

Comprehensive Evaluation of Anti-PD-1, Anti-PD-L1, Anti-CTLA-4 and Their Combined Immunotherapy in Clinical Trials: A Systematic Review and Meta-analysis

Ze Xiang
Jiayuan Li
Zhengyu Zhang
Chao Cen
Wei Chen
Bin Jiang
Yiling Meng
Ying Wang
Björn Berglund
1 more
Jian Wu

doi 10.3389/fphar.2022.883655

2,688 views
18 citations

Share on

Frontiers in Pharmacology

Frontiers in Pharmacology

Drugs Outcomes Research and Policies

Impact

24kTopic views
16kArticle views
7,284Article downloads